首页> 美国卫生研究院文献>The Journal of Biological Chemistry >A Cut above the Rest: Targeted Genome Editing Technologies in Human Pluripotent Stem Cells
【2h】

A Cut above the Rest: Targeted Genome Editing Technologies in Human Pluripotent Stem Cells

机译:超越其他:人类多能干细胞的靶向基因组编辑技术

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Human pluripotent stem cells (hPSCs) offer unprecedented opportunities to study cellular differentiation and model human diseases. The ability to precisely modify any genomic sequence holds the key to realizing the full potential of hPSCs. Thanks to the rapid development of novel genome editing technologies driven by the enormous interest in the hPSC field, genome editing in hPSCs has evolved from being a daunting task a few years ago to a routine procedure in most laboratories. Here, we provide an overview of the mainstream genome editing tools, including zinc finger nucleases, transcription activator-like effector nucleases, clustered regularly interspaced short palindromic repeat/CAS9 RNA-guided nucleases, and helper-dependent adenoviral vectors. We discuss the features and limitations of these technologies, as well as how these factors influence the utility of these tools in basic research and therapies.
机译:人类多能干细胞(hPSC)为研究细胞分化和模拟人类疾病提供了前所未有的机会。精确修饰任何基因组序列的能力是实现hPSC的全部潜能的关键。由于hPSC领域的巨大兴趣推动了新型基因组编辑技术的迅速发展,hPSC中的基因组编辑已从几年前的艰巨任务发展成为大多数实验室的常规程序。在这里,我们提供了主流基因组编辑工具的概述,包括锌指核酸酶,转录激活因子样效应子核酸酶,成簇的规则间隔的短回文重复序列/ CAS9 RNA引导的核酸酶以及辅助依赖的腺病毒载体。我们讨论了这些技术的特征和局限性,以及这些因素如何影响这些工具在基础研究和治疗中的效用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号